Crossed from claiming to demonstrating: management marks its own before/after line with repeated, recent proof
The model's full reasoning — Q2 2022 call → NOWe need answer only YES or NO. Need analyze transcript. Need determine if management conveys recently crossed from claiming to demonstrating something, with before/after contrast, repeated real events, fresh payoff ahead. Let's parse. Company Surgery Partners. They discuss results, M&A, de novos, ValueHealth partnership, physician recruiting, robotics, etc. Need find if management explicitly contrasts before vs now: "we used to talk about whether we could; now we are doing it routinely" etc. Potential candidates: - ValueHealth partnership: announced last quarter, now executing acquisitions. But is that a capability newly proven? They acquired minority stakes in 5 ASCs, majority interest in vascular ASC, 4 de novos. That's repeated. But management doesn't draw before/after contrast of "we couldn't before, now we can" maybe they say "as we discussed on our last call, we acquired..." Not really crossing from claim to demonstration? They had announced partnership, now executing. But is that a capability? Maybe. - Physician recruiting: They added 100 new physicians in Q2, 250 in H1. They say "Previously, we've shared with you the increasing contribution our newly recruited physicians bring... Our most recent 2022 cohorts are no exception... bringing more cases with higher net revenue per case than 2021 cohorts did in same period." That's not a before/after of capability; it's ongoing. - Robotics: They mention "we are preparing for next wave... considering all options... including increased use of robotics..." Not demonstrated. - De novo development: "In addition to the initial syndicated projects acquired from ValueHealth, there are multiple other de novos in development across our portfolio." Not crossing. - "We are the value in value-based care" - not. - "We have resumed business as usual" - not. - "Our business model continues to demonstrate durability" - not. - "We have done well overall in mitigating impacts" - not. - "We are not immune" - not. - "We have successfully managed these costs in line with expectation" - not. - "We are pleased to report... results demonstrate and reinforce how our business model is uniquely positioned" - not. - "The transition of procedures out of traditional acute care inpatient settings continues to accelerate. Joint replacements in our ASCs were up 32%... cardiac procedures increased nearly 9%.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| ASB | Associated Banc-Corp | Q1 2024 | 2024-04-25 | A |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| CNXC | Concentrix Corporation | Q1 2022 | 2022-03-30 | B |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| SXC | SunCoke Energy, Inc. | Q3 2021 | 2021-11-01 | A |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOSL | Fossil Group, Inc. | Q1 2018 | 2018-05-08 | C |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
DXCM · Q4 2023 → YESThe question is about whether management conveys that the company has recently crossed from claiming something to demonstrating it. YES The transcript shows management drawing a clear before/after contrast on the Malaysia manufacturing facility: previously they relied on established US facilities, but mid-year they opened a new site and are now ramping production with yields matching the US ones—real, repeated activity rather than a single event or plan. This is framed as 2023 being transformational, with the new capability already contributing to results and positioned for further scaling ahead. The primary-care expansion also fits as a demonstrated shift from long-term investment to immediate results (70% of new scripts), but the manufacturing crossing is the clearest match to the criteria.
LC · Q4 2021 → YESThe question is about whether management conveys that the company has recently crossed from claiming something to demonstrating it. YES The transcript shows management drawing a clear before/after line: Scott Sanborn describes closing 2021 in the strongest position after executing a strategy laid out in February, creating America's first digital marketplace bank; Tom Casey states the radical transformation over the last year is now complete as promised, contrasting it with 2019 4Q revenue and net income levels to highlight the fundamental change. The after-side is real and repeated—record revenue, doubled economics, NII recurring stream, multiple quarters of strong performance—backed by actual bank operations and deliveries.
KTB · Q3 2021 → YESThe question is about whether management conveys that the company has recently crossed from claiming something to demonstrating it. YES Management draws its own before/after line in Scott Baxter’s opening remarks: “we are doing things with both the Wrangler and Lee brands that we have simply never done before,” directly contrasting past practice with the current reality of new marketing campaigns (Lee launched October, Wrangler September). The after-side is 1) real and recent (Q3 results show 50 % growth in U.S. outdoor and 60 % growth in work wear versus 2019 baselines) and 2) repeated across multiple categories and brands, confirming the capability is now operating rather than a one-off event.